These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11825542)

  • 1. Treatment of hepatitis B and C following liver transplantation.
    Sponseller CA; Ramrakhiani S
    Curr Gastroenterol Rep; 2002 Feb; 4(1):52-62. PubMed ID: 11825542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
    Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
    Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
    Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation in viral hepatitis: prevention of recurrence.
    Roche B; Samuel D
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1153-69. PubMed ID: 19187873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B: progress in the last 15 years.
    Villamil FG
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S59-66. PubMed ID: 12362301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation.
    Katz LH; Tur-Kaspa R; Guy DG; Paul M
    Cochrane Database Syst Rev; 2010 Jul; (7):CD006005. PubMed ID: 20614442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosing cholestatic hepatitis secondary to precore/core promoter hepatitis B variant with lamivudine resistance: successful retransplantation with combination adefovir dipivoxil and hepatitis B immunoglobulin.
    Lo CM; Cheung ST; Ng IO; Liu CL; Lai CL; Fan ST
    Liver Transpl; 2004 Apr; 10(4):557-63. PubMed ID: 15048802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation.
    Singer GA; Zielsdorf S; Fleetwood VA; Alvey N; Cohen E; Eswaran S; Shah N; Chan EY; Hertl M; Fayek SA
    Transplant Proc; 2015 Mar; 47(2):478-84. PubMed ID: 25769595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and risk factors of the HBV recurrence after orthotopic liver transplantation: 160 cases follow-up study.
    Xie SB; Zhu JY; Ying Z; Zeng LJ; Chao M; Lu MQ
    Transplantation; 2010 Oct; 90(7):786-90. PubMed ID: 20703179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues.
    Schreibman IR; Schiff ER
    Ann Clin Microbiol Antimicrob; 2006 Apr; 5():8. PubMed ID: 16600049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liver transplantation in patients with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus].
    Duclos-Vallée JC; Roche B; Samuel D
    Presse Med; 2009 Sep; 38(9):1281-9. PubMed ID: 19574023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy.
    Wong SN; Chu CJ; Wai CT; Howell T; Moore C; Fontana RJ; Lok AS
    Liver Transpl; 2007 Mar; 13(3):374-81. PubMed ID: 17318855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New developments in therapy of chronic hepatitis B. When are nucleoside analogs indicated?].
    Petry W; Erhardt A; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Jan; 38(1):77-87. PubMed ID: 10689749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic use of low-dose, on-demand, intramuscular hepatitis B immunoglobulin and lamivudine after liver transplantation.
    Karademir S; Astarcioğlu H; Akarsu M; Ozkardesler S; Ozzeybek D; Sayiner A; Akan M; Tankurt E; Astarcioğlu I
    Transplant Proc; 2006 Mar; 38(2):579-83. PubMed ID: 16549180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of recurrent hepatitis B post-liver transplantation.
    Lok AS
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S67-73. PubMed ID: 12362302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence.
    Biliotti E; Zacharia S; Grieco S; Spaziante M; Giusto M; Merli M; Gallinaro V; Taliani G
    J Chemother; 2012 Dec; 24(6):369-72. PubMed ID: 23174103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates.
    Gane EJ; Patterson S; Strasser SI; McCaughan GW; Angus PW
    Liver Transpl; 2013 Mar; 19(3):268-74. PubMed ID: 23447403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
    Akyildiz M; Karasu Z; Zeytunlu M; Aydin U; Ozacar T; Kilic M
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2130-4. PubMed ID: 18031370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-hepatitis primary disease does not influence 6-year survival after liver transplantation beyond 1 year.
    Caccamo L; Colledan M; Rossi G; Gridelli B; Maggi U; Vannelli A; Damilano I; Lucianetti A; Paone G; Gatti S; Reggiani P; Fassati LR
    Transpl Int; 1998; 11 Suppl 1():S212-20. PubMed ID: 9664982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.